Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from camellia
Reexamination Certificate
2005-08-31
2009-08-25
Hoffman, Susan C (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from camellia
C424S756000, C424S725000
Reexamination Certificate
active
07579026
ABSTRACT:
An antioxidant-promoting composition that increases antioxidant defense potential in a subject is disclosed comprisingBacopa monnieraextract; milk thistle extract, ashwagandha powder, green tea extract, Gotu kola powder,Ginko bilobaleaf extract;Aloe verapowder; turmeric extract; and N-acetyl cysteine. The antioxidant-promoting composition of the invention safely induces cellular antioxidant potential to achieve an overall net decrease in oxidative stress without the undesirable side-effects associated with the individual components of the antioxidant-promoting composition. Also disclosed is a method for reducing the undesirable side-effects of free radicals in a subject by administering to a subject in need of such antioxidants an effective amount of antioxidant-promoting composition of the invention.
REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 5854287 (1998-12-01), Weglicki
patent: 5939395 (1999-08-01), Yu et al.
patent: 6093404 (2000-07-01), Kattan
patent: 6162438 (2000-12-01), Tomer et al.
patent: 6372265 (2002-04-01), Saito
patent: 6495170 (2002-12-01), Smit et al.
patent: 6646013 (2003-11-01), Barker et al.
patent: 6841177 (2005-01-01), Quintanilla Almagro et al.
patent: 7241461 (2007-07-01), Myhill et al.
patent: 2002/0086067 (2002-07-01), Choi
patent: 2003/0072823 (2003-04-01), Fleischner
patent: WO 01/21185 (2001-03-01), None
Chen (International Journal of Cardiology (1993), vol. 41, pp. 103-108).
Falchi et al. (Drugs Exptl. Clin. Res. (1983), vol. 9, No. 6, pp. 419-422).
Tripathi et al. (Indian Journal of Experimental Biology (1996), vol. 34, pp. 523-526).
Dwivedi et al. (Journal of Medicinal and Aromatic Plant Sciences (2000), vol. 22, pp. 616-620).
Mukhtar (Am J Clin Nutr (2001), vol. 71(suppl), pp. 1698S-1702S).
Reddy and Lokesh (1994) Food and Chemical Toxicology 32(3):279-283.
Albert, “The Role of C-Reactive Protein in Cardiovascular Disease Risk,”Curr. Cardio. Rep., 2000; vol. 2: pp. 274-279.
Alexandrakis, et al., “The Relation Between Bone Marrow Angiogenesis and the Proliferation Index Ki-67 in Multiple Myeloma,”J. Clin. Pathol., 2004; vol. 57: pp. 856-860.
Baeuerle, et al., “I B: A Specific Inhibitor of the NF- B Transcription Factor,”Science, 1988; vol. 242: pp. 540-546.
Al-Shaer, “C-Reactive Protein and Risk of Colon Cancer,”JAMA, 2004; vol. 291, No. 23: pp. 2818-2819.
Anderson, et al., “Differential Response of Human Ovarian Cancer Cells to Induction of Apoptosis by Vitamin E Succinate and Vitamin E Analogue, -TEA,”Cancer Res., 2004; vol. 64: pp. 4263-4269.
Baker, et al., “Reduced RBC Versus Plasma Microvascular Flow Due to Endotoxin,”Circul. Shock, 1986; vol. 20: pp. 127-139.
Barbosa, et al., “Decreased Oxidative Stress in Patients with Ulcerative Colitis Supplemented with Fish Oil -3 Fatty Acids,”Nutrition, 2003; vol. 19: pp. 837-842.
Bhattacharya, et al., “Antioxidant Activity of Glycowithanolides fromWithania sominfera,” Ind. J. Exper. Biol., 1997; vol. 35: pp. 236-239.
Bhattacharya, et al., “Antixidant Activity ofBacopa monnierain Rat Frontal Cortex, Striatum and Hippocampus,”Phytother. Res., 2000; vol. 14: pp. 174-179.
Bogarty, et al., “Biological Profiles in Subjects with Recurrent Acute Coronary Events Compared with Subjects with Long-standing Stable Angina,”Circulation, 2001; vol. 103: pp. 3062-3068.
Bolibar, et al., “Short-term Prognostic Value of Lipid Measurements in Patients with Angina Pectoris,”Thromb. Haemost., 2000; vol. 84; pp. 955-960.
Bose, et al., “Membrane Lipid Peroxidation by UV-A: Mechanism and Implications,”Biotech. App. Biochem., 1990; vol. 12: pp. 557-561.
Boyd-Kimball, et al., “Rodent A (1-42) Exhibits Oxidative Stress Properties Similar to Those of Human A (1-42): Implications for Proposed Mechanisms of Toxicity,”J. Alzh. Dis., 2004; pp. 515-525.
Bridi, et al., “The Antioxidant Activity of Standardized Extract ofGinkgo biloba(EGb 761) in Rats,”Phytother. Res., 2001; vol. 15: pp. 449-451.
Chaudhri, et al., “Reactive Oxygen Species Facilitate the In Vitro and In Vivo Lipopolysaccharide-induced Release of Tumor Necrosis Factor,”J. Immun., 1989; vol. 142, No. 4: pp. 1290-1294.
Cole, et al., “Metal-catalyzed Oxidation of Alpha Synuclein: Helping to Define the Relationship Between Oligomers, Protofibrils and Filaments,”JBC Papers in Press, Dec. 21, 2004; Man. M409946200.
Dawes, et al., “Rheumatoid Arthritis: Treatment which Controls the C-Reactive Protein and Erythrocyte Sedimentation Rate Reduces Radiological Progression,”Brit. J. Rheum., 1986; vol. 25: pp. 44-49.
Demopoulos, “The Basis of Free Radical Pathology,”Fed. Proc., 1973; vol. 32, No. 8: pp. 1859-1861.
Dessein, et al., “Cardiovascular Risk in Rheumatoid Arthritis Versus Osteoarthritis” Acute Phase Response Related Decreased Insulin Sensitivity and High-density Lipoprotein Cholesterol as well as Clustering of Metabolic Syndrome Features in Rheumatoid Arthritis,Arthr. Res., 2002; vol. 4, No. R5: pp. 1-6.
Drash, et al., “Effect of Probucol on Development of Diabetes Mellitus in BB Rats,”Amer. J. Card., 1988; vol. 62: pp. 27B-30B.
D'Souza, et al., “Brine Shrimp Lethality Assay ofBacopa monnieri,” Phytother. Res., 2002; vol. 16: pp. 197-198.
Duh, et al., “Tumor Necrosis Factor Activates Human Immunodeficiency Virus Type 1 Through Induction of Nuclear Factor Binding to the NF-B Sites in the Long Terminal Repeat,”Proc. Natl. Acad. Sci.USA, 1989; vol. 86: pp. 5974-5978.
Eck, et al., “Low Concentrations of Acid-Soluble Thiol (Cysteine) in the Blood Plasma of HIV-1 Infected Patients,”Biol. Chem., 1989; vol. 370: pp. 101-108.
Eck, et al., “Influence of the Extracellular Glutamate Concentration on the Intracellular Cyst(e)ine Concentration in Macrophages and on the Capacity to Release Cysteine,”Biol. Chem., 1989; vol. 370: pp. 109-113.
Hag, et al., “Immunomodulation by Neutrophil Myeloperoxidase and Hydrogen Peroxide: Differential Susceptibility of Human Lymphocyte Functions,”J. Immun., 1986; vol. 136, No. 9: pp. 3420-3426.
Fagan, et al., “Serum Levels of C-reactive Proteinin Crohn's Disease and Ulcerative Colitis,”Eur. J. Clin. Invest., 1982; vol. 12: pp. 351-359.
Fantone, et al., “Role of Oxygen-Derived Free Radicals and Metabolites in Leukocyte-dependent Inflammatory Reactions,”AJP, 1982; vol. 107, No. 3: pp. 397-418.
Fischman, et al., “Inhibition of Lectin-induced Lymphocyte Activation by 2-Cyclohexene-1-One: Decreased Intracellular Glutathione Inhibits an Early Event in the Activation Sequence,”J. Immun., 1981; vol. 127, No. 6: pp. 2257-2262.
Fraser, et al., “Turnover of Type II Collagen and Aggrecan in Cartilage Matrix at the Onset of Inflammatory Arthritis in Humans,”Arth. Rheum., 2003; vol. 48, No. 11: pp. 3085-3095.
Hamanaka, et al., “Protoprotective Effect on Topically Applied Superoxide Dismutase on Sunburn Reaction in Comparison with Sunscreen,”J. Derm., 1990; vol. 17: pp. 595-598.
Haverkate, et al., “Haemostasis Factors in Angina Pectoris; Relation to Gender, AGen and Acute-Phase Reaction,”Thromb. Haemost., 1995; vol. 73, No. 4: pp. 561-567.
Hebbel, et al., “Spontaneous Oxygen Radical Generation by Sickle Erythrocytes,”J. Clin. Invest., 1982; vol. 70: pp. 1253-1259.
Hernandez, et al., “Calcium Antagonists and Atherosclerosis Protection in Hypertension,”Amer. J. Therap., 2003; vol. 10: pp. 409-414.
Machiedo, et al., “Temporal Relationship of Hepatocellular Dysfunction and Ischemia in Sepsis,”Arch. Surg., 1988; vol. 123: pp. 424-427.
Kalebic, et al., “Suppression of Human Immunodeficiency Virus Expression in Chronically Infected Monocytic Cells by Glutathione, Glutathione Ester, andN-acetylcysteine,”Proc. Natl. Acad. Sci.USA, 1991; vol. 88: pp. 986-990.
Kar, et al.,
Driscoll William J.
Myhill Paul R.
Hoffman Susan C
Lifeline Nutraceuticals Corporation
Swanson & Bratschun L.L.C.
LandOfFree
Methods for enhancing antioxidant enzyme activity and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for enhancing antioxidant enzyme activity and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for enhancing antioxidant enzyme activity and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4131065